ACS Medicinal Chemistry Letters p. 1335 - 1341 (2020)
Update date:2022-08-02
Topics:
Hiramatsu, Atsushi
Hirooka, Yasuo
Hisaichi, Katsuya
Imagawa, Akira
Iwaki, Yuzo
Katoh, Makoto
Kobayashi, Juta
Komichi, Yuka
Maeda, Tatsuo
Matsumura, Naoya
Moriguchi, Hideki
Nakatani, Shingo
Nishiyama, Taihei
Ohhata, Akira
Okabe, Yasuyuki
Okada, Masahiro
Ota, Hiroto
Saga, Hiroshi
Sugiyama, Tetsuya
Watanabe, Toshihide
Yamamoto, Shingo
Lysophosphatidic acid (LPA) is a bioactive lipid mediator that elicits a number of biological functions, including smooth muscle contraction, cell motility, proliferation, and morphological change. LPA is endogenously produced by autotaxin (ATX) from extracellular lysophosphatidylcholine (LPC) in plasma. Herein, we report our medicinal chemistry effort to identify a novel and highly potent ATX inhibitor, ONO-8430506 (20), with good oral availability. To enhance the enzymatic ATX inhibitory activity, we designed several compounds by structurally comparing our hit compound with the endogenous ligand LPC. Further optimization to improve the pharmacokinetic profile and enhance the ATX inhibitory activity in human plasma resulted in the identification of ONO-8430506 (20), which enhanced the antitumor effect of paclitaxel in a breast cancer model.
View MoreChengdu CSH Pharmaceutical Co.,ltd
Contact:+86-(28)-85321971
Address:Block B,New Hope Int. Tian Fu New District, Chengdu, Sichuan, China
Goldwills Pharmaceuticals Co., Ltd.
Contact:0916-2237889 13991621155
Address:North Suburb of Hanzhong city, Shaanxi Province
Contact:+86-(0)21-3770 9035
Address:Room 301, Building 2, Meijiabang Road 1508, Shanghai China
FREEBARQUE DEVELOPMENT GROUP LIMITED
Contact:+86(0)10-5109 5335 or 5109 5345
Address:Room602,Block1-B,LINGDI OFFICE,NO.13 BEIYUAN ROAD
Hangzhou Think Chemical Co. Ltd
website:http://www.thinkchem.com/
Contact:86-571-89986307/81956191/81956084/81956192
Address:Room 501-502, Tower E, Yuanjian Building, Yuanyang International Center, Hangzhou-310011, China
Doi:10.1021/ja00018a040
(1991)Doi:10.1016/j.bmcl.2011.10.099
(2012)Doi:10.1016/j.tetlet.2005.03.193
(2005)Doi:10.1016/j.inoche.2011.10.004
(2012)Doi:10.1055/s-0031-1289570
(2011)Doi:10.1021/acs.orglett.1c01177
(2021)